CG Oncology, Inc. — Form 4
Filed November 18, 2026 · analyzed by the Insider Agent
4
▲ Likely positive
significance 68/100
What the filing says
Chief Executive Officer Kuan Arthur (CGON) bought 30K shares (~$2.4M) on the open market (12% of holdings). Open-market insider purchase — historically a bullish signal.
Why this rating
Open-market insider purchase — historically a bullish signal.
See more from November 18, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.